Feel Free To Contact Us at Subscribe to our Newsletter and get the latest updates in the field of Holistic Medicine CJC-1295 is a game-changer on its ownbut in 2025, more functional medicine providers are taking it to the next level by stacking it with other performance and longevity peptides
NEW YORK Ro is now working with Eli Lilly to launch the recently FDA-approved Zepbound (tirzepatide) KwikPen nationwide on its platform
ANZ J Surg 74(7):573576
PCD is characterized by low plasma carnitine levels, reduced intracellular carnitine, and increased urinary loss.[5] Carnitine is transported intracellularly via OCTN2, which is expressed predominantly in skeletal and cardiac muscles, and kidneys.[3] Decreased OCTN2 on the plasma membrane results in a reduced intracellular update of carnitine.[5] In kidneys, this results in reduced reabsorption of carnitine, and patients with PCD may lose up to 95% of the filtered carnitine in the urine.[6] The parents of a child with PCD, who are heterozygous carriers, may lose twice or thrice the levels of normal urinary excretion.[6] The plasma concentration of acyl-carnitine esters is also low in PCD.[5] Epidemiology The incidence of Primary carnitine deficiency is different based on ethnicity
Dihexa: A synthetic peptide-like compound discussed in some biohacking circles for neuroplasticity and cognitive enhancement
As of late 2025, his role was expanded to oversee not just R&D, but the entire global product strategy for metabolic, immunology, and neuroscience 4.4
